Contact
searchSearch
HMP Global

Volume 18 - Issue 2 - February, 2006

Case Report
Treatment of Spontaneous Coronary Dissection with Drug-Eluting Stents — Late Clinical, Angiographic and IVUS Follow Up
08/01/2008
Adrian P. Banning, MD, PhD, MBBS; Italo Porto, MD, PhD; William J. van Gaal, III, MD, MBBS, FRACP
Spontaneous coronary artery dissection (SCAD) is a rare condition which may result in sudden coronary occlusion, acute myocardial infarction (AMI) and sudden cardiac death.1–3 We previously reported a case of SCAD involving the left anterior...
Spontaneous coronary artery dissection (SCAD) is a rare condition which may result in sudden coronary occlusion, acute myocardial infarction (AMI) and sudden cardiac death.1–3 We previously reported a case of SCAD involving the left anterior...
Spontaneous coronary artery...
08/01/2008
Journal of Invasive Cardiology
Case Report
Late “Adult Form” Scimitar Syndrome Presenting with “Infant Form” Complications
08/01/2008
Richard A. Krasuski, MD; Brian W. Zagol, MD; Scott Book, MD
Scimitar syndrome is a rare congenital cardiopulmonary anomaly that carries a poor prognosis for individuals who are diagnosed within their first year of life.1 These patients often present with pulmonary hypertension and right-sided...
Scimitar syndrome is a rare congenital cardiopulmonary anomaly that carries a poor prognosis for individuals who are diagnosed within their first year of life.1 These patients often present with pulmonary hypertension and right-sided...
Scimitar syndrome is a rare...
08/01/2008
Journal of Invasive Cardiology
Case Report
Mechanical Reperfusion during Acute Myocardial Infarction in a Patient with Dextrocardia
08/01/2008
Juan Zambrano, MD; Aristides De la Hera, MD; Eduardo de Marchena, MD
A 53-year-old male with history of hypertension and hypercholesterolemia presented to the emergency room with new-onset chest pain for the last hour. Clinical examination was remarkable for a right-sided point of maximal impulse, with the...
A 53-year-old male with history of hypertension and hypercholesterolemia presented to the emergency room with new-onset chest pain for the last hour. Clinical examination was remarkable for a right-sided point of maximal impulse, with the...
A 53-year-old male with history...
08/01/2008
Journal of Invasive Cardiology
Letters to the Editor
Iodixanol and Chronic Kidney Disease
08/01/2008
Gilbert Deray, MD
Dear Editor, I read with great interest the Tadros, et al. article1 entitled Iso-osmolar Radiocontrast Iodixanol in Patients with Chronic Kidney Disease (J Invasive Cardiol 2005;17:211–215). They concluded that the volume of iso-osmolar...
Dear Editor, I read with great interest the Tadros, et al. article1 entitled Iso-osmolar Radiocontrast Iodixanol in Patients with Chronic Kidney Disease (J Invasive Cardiol 2005;17:211–215). They concluded that the volume of iso-osmolar...
Dear Editor, I read with great...
08/01/2008
Journal of Invasive Cardiology
Editorial Message
Feb-06
08/01/2008
Richard E. Shaw, PhD, FACC
Dear Readers, This issue of the Journal of Invasive Cardiology includes several interesting research articles, commentaries and selections from the Journal’s special sections, Adjunctive Therapy, Pediatric Intervention, and Clinical Images....
Dear Readers, This issue of the Journal of Invasive Cardiology includes several interesting research articles, commentaries and selections from the Journal’s special sections, Adjunctive Therapy, Pediatric Intervention, and Clinical Images....
Dear Readers, This issue of the...
08/01/2008
Journal of Invasive Cardiology
Case Report
Refractory Coronary Vasospasm following Drug-Eluting Stent Placement Treated with Cyproheptadine
08/01/2008
Adel El-Bialy, MD; Michael Shenoda, MD; Chris Caarang, MD
Over the years, there have been many implicated mechanisms in the pathogenesis of coronary vasospasm. Some of these have included the release of endothelin by vascular endothelial cells,1 loss of endothelial-dependent relaxation following...
Over the years, there have been many implicated mechanisms in the pathogenesis of coronary vasospasm. Some of these have included the release of endothelin by vascular endothelial cells,1 loss of endothelial-dependent relaxation following...
Over the years, there have been...
08/01/2008
Journal of Invasive Cardiology
Case Report
Refractory Hypoxemia after Mitral Valve Surgery: An Unusual
Cause and Its Successful Percutaneous Treatment
08/01/2008
Jonathan Hyde, MD; David Hildick-Smith, MD, MBBS, FRCP; Alexander Sirker, MD
A variety of approaches are used for mitral valve repair and replacement operations. Rare complications specific to the surgical method may need to be considered if patients encounter unexplained problems postoperatively. We discuss such an...
A variety of approaches are used for mitral valve repair and replacement operations. Rare complications specific to the surgical method may need to be considered if patients encounter unexplained problems postoperatively. We discuss such an...
A variety of approaches are used...
08/01/2008
Journal of Invasive Cardiology
Case Report
Fibromuscular Dysplasia and Acute Myocardial Infarction: Evidence for a Unique Clinical and Angiographic Pattern
08/01/2008
Jose F. Huizar, MD; Hani Kozman, MD; Ashish Awasthi, MD
Myocardial infarction (MI) typically occurs in the setting of atherosclerotic coronary artery disease (CAD). However, there are other causes of MI unrelated to atherosclerosis that include spontaneous dissection of the coronary arteries,...
Myocardial infarction (MI) typically occurs in the setting of atherosclerotic coronary artery disease (CAD). However, there are other causes of MI unrelated to atherosclerosis that include spontaneous dissection of the coronary arteries,...
Myocardial infarction (MI)...
08/01/2008
Journal of Invasive Cardiology
Case Report
Percutaneous Coronary Intervention in Anomalous Right Coronary Arteries Arising from the Left Sinus of Valsalva:
A Report of Tw
08/01/2008
Konstantinos Spargias, MD, PhD; Panagiotis Kariofyllis, MD; Sophia Mavrogeni, MD
Congenital anomalies of the origin and distribution of the coronary arteries are infrequent and are found in 0.3–1.2% of patients undergoing coronary angiography.1–3 The prevalence is greater if the origin of a coronary artery from an ectopic...
Congenital anomalies of the origin and distribution of the coronary arteries are infrequent and are found in 0.3–1.2% of patients undergoing coronary angiography.1–3 The prevalence is greater if the origin of a coronary artery from an ectopic...
Congenital anomalies of the...
08/01/2008
Journal of Invasive Cardiology
Clinical Images
Novel Intracoronary Steerable Support Catheter for Complex Coronary Intervention
08/01/2008
Shing-Chiu Wong, MD; Srihari S. Naidu, MD
Case Description. A 69-year-old female with hypertension and hyperlipidemia presented with a 2-month history of worsening exertional angina. Nuclear perfusion imaging indicated ischemia in the inferior and inferoposterior walls, with...
Case Description. A 69-year-old female with hypertension and hyperlipidemia presented with a 2-month history of worsening exertional angina. Nuclear perfusion imaging indicated ischemia in the inferior and inferoposterior walls, with...
Case Description. A 69-year-old...
08/01/2008
Journal of Invasive Cardiology
Clinical Images
Saphenous Vein Graft Rheology Simulating a Thrombotic Lesion
08/01/2008
Eugene V. Pomerantsev, MD; Margaret Ferrell, MD; Adrian F. Low, MD, MBBS
Case Presentation. A 59-year-old male was admitted for accelerated angina. Serial ECGs and cardiac enzymes ruled out a myocardial infarction. He had undergone coronary artery bypass grafting 4 years before, as well as coronary stenting of an...
Case Presentation. A 59-year-old male was admitted for accelerated angina. Serial ECGs and cardiac enzymes ruled out a myocardial infarction. He had undergone coronary artery bypass grafting 4 years before, as well as coronary stenting of an...
Case Presentation. A 59-year-old...
08/01/2008
Journal of Invasive Cardiology
Original Contribution
Clinical and Economic Outcomes of Embolic Complications
and Strategies for Distal Embolic Protection during Percutaneous Corona
08/01/2008
Akshay Gupta, MD; Shaun R. Senter, MD, MS; Lloyd W. Klein, MD; Sandeep Nathan, MD, MSc, FACC, FSCAI
Over 500,000 coronary artery bypass grafts in 314,000 cases were performed in the United States in 2000, however, over half of all vein grafts develop significant stenosis within 10 years.1,2 Percutaneous coronary intervention in saphenous...
Over 500,000 coronary artery bypass grafts in 314,000 cases were performed in the United States in 2000, however, over half of all vein grafts develop significant stenosis within 10 years.1,2 Percutaneous coronary intervention in saphenous...
Over 500,000 coronary artery...
08/01/2008
Journal of Invasive Cardiology
Original Contribution
Percutaneous Transvenous Mitral Commissurotomy Using Metallic Commissurotome: Long-Term Follow-Up Results
08/01/2008
Sivasubramanian Sivasankaran, MD, DM; Jaganmohan Achuthan Tharakan, MBBS, MD, DM; Sivadasan Pillai Harikrishnan, MD, DM; Kavassery Mahadevan Krishnamoorthy, MD, DM; Anil Bhat, MD; Thomas Titus, MD; Ajith Kumar, MD
Percutaneous transmitral commissurotomy (PTMC) has been established as an effective treatment for mitral stenosis (MS) and is now the procedure of choice.1–6 Of the procedures available to treat mitral stenosis, percutaneous valvotomy using...
Percutaneous transmitral commissurotomy (PTMC) has been established as an effective treatment for mitral stenosis (MS) and is now the procedure of choice.1–6 Of the procedures available to treat mitral stenosis, percutaneous valvotomy using...
Percutaneous transmitral...
08/01/2008
Journal of Invasive Cardiology
Original Contribution
Glycoprotein IIb/IIIa Inhibitors during Rescue Percutaneous Coronary Intervention in Acute Myocardial Infarction
08/01/2008
Michael Kapeliovich, MD; Shlomo Amikam, MD; Walter Markiewicz, MD; Haim Hammerman, MD; Mahmoud Sileiman, MD; Monther Boulus, MD; Rafael Beyar, MD, DSc, MPH; Luis Gruberg, MD; Ehud Grenadier, MD
Fibrinolytic therapy for acute myocardial infarction, even with the most efficient regimens available, is fraught with a substantial proportion of failures to re-establish normal blood flow in the occluded vessel.1,2 Failure to achieve prompt...
Fibrinolytic therapy for acute myocardial infarction, even with the most efficient regimens available, is fraught with a substantial proportion of failures to re-establish normal blood flow in the occluded vessel.1,2 Failure to achieve prompt...
Fibrinolytic therapy for acute...
08/01/2008
Journal of Invasive Cardiology
Commentary
Adjunctive Antiplatelet Therapy during Rescue PCI
08/01/2008
John J. Young, MD; Dean J. Kereiakes, MD, FACC, MSCAI
The treatment of ST-segment elevation myocardial infarction (STEMI) continues to evolve due to the adoption of antiplatelet and anticoagulation regimens in combination with pharmacologic (fibrinolysis) and/or mechanical reperfusion. Rapid,...
The treatment of ST-segment elevation myocardial infarction (STEMI) continues to evolve due to the adoption of antiplatelet and anticoagulation regimens in combination with pharmacologic (fibrinolysis) and/or mechanical reperfusion. Rapid,...
The treatment of ST-segment...
08/01/2008
Journal of Invasive Cardiology
Sequential Balloon Dilatation for Combined Aortic Valvular Stenosis and Coarctation of the Aorta in a Single Catheterization Pro
08/01/2008
Kursad Tokel, MD; Selman Vefa Yildirim, MD; Birgul Varan, MD; Enver Ekici, MD
Combined aortic valvular stenosis (AVS) and coarctation of the aorta (CoA) is uncommon.3–5 This combination was detected in 7% of a large group of children with CoA who underwent balloon angioplasty.2 The long-term results of percutaneous...
Combined aortic valvular stenosis (AVS) and coarctation of the aorta (CoA) is uncommon.3–5 This combination was detected in 7% of a large group of children with CoA who underwent balloon angioplasty.2 The long-term results of percutaneous...
Combined aortic valvular...
08/01/2008
Journal of Invasive Cardiology
Biodegradable Stents: They Do Their Job and Disappear
08/01/2008
Ron Waksman, MD
Coronary stenting has become the default device in percutaneous coronary interventions (PCIs). Coronary stents are used as a mechanical means to overcome the major limitations of balloon angioplasty with enabling scaffolding and the...
Coronary stenting has become the default device in percutaneous coronary interventions (PCIs). Coronary stents are used as a mechanical means to overcome the major limitations of balloon angioplasty with enabling scaffolding and the...
Coronary stenting has become the...
08/01/2008
Journal of Invasive Cardiology
Rapid Communication
Percutaneous Retrograde Revascularization of Lower Extremity Vessels by Using the Dorsalis Pedis Artery: Two Case Reports
08/01/2008
Thomas P. Davis, MD, FACC; Ashish Awasthi, MD; Yassar Almanaseer, MD; Thomas A. LaLonde, MD
Peripheral artery disease (PAD) is commonly found in association with coronary artery disease (CAD) and is also considered a marker for CAD.1,2 There has been an increase in the treatment options for PAD with an increasing number of...
Peripheral artery disease (PAD) is commonly found in association with coronary artery disease (CAD) and is also considered a marker for CAD.1,2 There has been an increase in the treatment options for PAD with an increasing number of...
Peripheral artery disease (PAD)...
08/01/2008
Journal of Invasive Cardiology
Editorial
Coronary Bifurcation Stenting: From Crush to Culotte. Avoiding Limerence and Meme Propagation?
08/01/2008
Roberto Baglini, MD, PhD; Duccio Baldari, MD; Giuseppe Mezzapelle, MD
The Wikipedia term “crush” refers to a short-lived and unrequited love or limerence (“to crush on”). The primary characteristics of limerence can be summarized as intrusive, perhaps obsessive thinking about the limerent object and acute...
The Wikipedia term “crush” refers to a short-lived and unrequited love or limerence (“to crush on”). The primary characteristics of limerence can be summarized as intrusive, perhaps obsessive thinking about the limerent object and acute...
The Wikipedia term “crush”...
08/01/2008
Journal of Invasive Cardiology
Procedural Success and 30-Day Outcomes between CYPHER™ and TAXUS® Stent Implantation for the Treatment of Bifurcation Lesions —
08/01/2008
Chi-Hang Lee, MD, MBBS, MRCP; Huay-Cheem Tan, MBBS, MD; Swee Guan Teo, MBBS, MD; Yean-Teng Lim, MBBS, MD; Hwee Bee Wong, MSc, MD; Jun Jie Zhang, MD; Chao Yang Soon, MD; Adrian F. Low, MD, MBBS
CYPHER™ (sirolimus-eluting stent, Cordis, Johnson and Johnson, Miami, Florida) and TAXUS® (polymer-based paclitaxel-eluting stent, Boston Scientific Corporation, Natick, Massachusetts) stents are the two drug-eluting stents (DES) currently...
CYPHER™ (sirolimus-eluting stent, Cordis, Johnson and Johnson, Miami, Florida) and TAXUS® (polymer-based paclitaxel-eluting stent, Boston Scientific Corporation, Natick, Massachusetts) stents are the two drug-eluting stents (DES) currently...
CYPHER™ (sirolimus-eluting...
08/01/2008
Journal of Invasive Cardiology
Commentary
Bifurcation Intervention: Keep it Simple
08/01/2008
James B. Hermiller, MD, FACC, MSCAI
The percutaneous treatment of bifurcation lesions remains suboptimal. A frequent problem, accounting for 10–20% of coronary lesions undergoing percutaneous coronary intervention (PCI), the bifurcation is plagued by acute technical challenges,...
The percutaneous treatment of bifurcation lesions remains suboptimal. A frequent problem, accounting for 10–20% of coronary lesions undergoing percutaneous coronary intervention (PCI), the bifurcation is plagued by acute technical challenges,...
The percutaneous treatment of...
08/01/2008
Journal of Invasive Cardiology
Original Contribution
Early Ambulation and Variability in Anticoagulation during Elective Coronary Stenting with a Single Intravenous Bolus
of Low-Do
08/01/2008
Jose A.F. Ramires, MD; Eulogio E. Martinez, MD; Marc S. Cohen, MD; Pedro A. Lemos, MD; Silvio Zalc, MD; Antonio Esteves, MD; Expedito E. Ribeiro, MD; Pedro Horta, MD; Jose C. Nicolau, MD
Low-molecular weight heparin (LMWH), especially enoxaparin, and unfractionated heparin (UFH), is recommended in the early medical management of acute coronary syndromes.1,2 Compared to intravenous UFH, subcutaneous LMWH has a more predictable...
Low-molecular weight heparin (LMWH), especially enoxaparin, and unfractionated heparin (UFH), is recommended in the early medical management of acute coronary syndromes.1,2 Compared to intravenous UFH, subcutaneous LMWH has a more predictable...
Low-molecular weight heparin...
08/01/2008
Journal of Invasive Cardiology

News

thrombectomy
Penumbra Launches Lightning Flash 3.0 — The Next Evolution in CAVT Technology
01/27/2026
Penumbra recently launched the Lightning Flash® 3.0 Computer Assisted Vacuum Thrombectomy (CAVT™) system, which includes significant upgrades that further advance our leading venous thromboembolism (VTE) platform.
Penumbra recently launched the Lightning Flash® 3.0 Computer Assisted Vacuum Thrombectomy (CAVT™) system, which includes significant upgrades that further advance our leading venous thromboembolism (VTE) platform.
Penumbra recently launched the...
01/27/2026
Cath Lab Digest
AI Cardiac Imaging Software
Study Reveals Stark Disconnect Between Americans’ Desire for Preventive Cardiac Screening and Care They Can Access
01/27/2026
New York, NY – In the lead-up to American Heart Health Month, a new national study reveals a stark disconnect between Americans’ desire for preventive cardiac screening and the care they can access. Despite heart disease remaining the leading...
New York, NY – In the lead-up to American Heart Health Month, a new national study reveals a stark disconnect between Americans’ desire for preventive cardiac screening and the care they can access. Despite heart disease remaining the leading...
New York, NY – In the lead-up to...
01/27/2026
Cath Lab Digest
Patent Foramen Ovale Detection
BURL Concepts Announces First Human Uses of FOQUS Ultrasound System for Patent Foramen Ovale (PFO) Detection
01/27/2026
The FOQUS ultrasound system, powered by SONAS technology, includes a transcranial headset system. The system introduces a new method to assist physicians in diagnosing a PFO, addressing the need for diagnostic tools that are both faster,...
The FOQUS ultrasound system, powered by SONAS technology, includes a transcranial headset system. The system introduces a new method to assist physicians in diagnosing a PFO, addressing the need for diagnostic tools that are both faster,...
The FOQUS ultrasound system,...
01/27/2026
Cath Lab Digest
AI Plaque analysis
Aetna Approves Coverage for Cleerly's AI Cardiovascular Imaging Analysis
01/21/2026
DENVER, CO – Cleerly, focused on AI-based cardiovascular imaging, announced that Aetna will begin covering Cleerly® LABS plaque analysis effective immediately. Aetna, which covers more than 20+ million lives,...
DENVER, CO – Cleerly, focused on AI-based cardiovascular imaging, announced that Aetna will begin covering Cleerly® LABS plaque analysis effective immediately. Aetna, which covers more than 20+ million lives,...
DENVER,...
01/21/2026
Cath Lab Digest
AI Plaque analysis
Coverage Unlocks Reimbursable AI Plaque Quantification With Circle Cardiovascular Imaging's cvi42|Plaque
01/21/2026
CALGARY, Alberta -- Circle Cardiovascular Imaging Inc. (Circle CVI), focused on cardiovascular imaging post-processing, announced that clinical practices using its FDA 510(k)-cleared cvi42 with AI-enabled plaque...
CALGARY, Alberta -- Circle Cardiovascular Imaging Inc. (Circle CVI), focused on cardiovascular imaging post-processing, announced that clinical practices using its FDA 510(k)-cleared cvi42 with AI-enabled plaque...
CALGARY, Alberta -- Circle...
01/21/2026
Cath Lab Digest
Acquisitions
Haemonetics Acquires Vivasure Medical Limited
01/21/2026
Vivasure's PerQseal® Elite system uses a proprietary bioabsorbable patch to seal large-bore (up to 26 F) arteriotomies and venotomies from inside the vessel, offering a sutureless, fully absorbable solution for structural heart and...
Vivasure's PerQseal® Elite system uses a proprietary bioabsorbable patch to seal large-bore (up to 26 F) arteriotomies and venotomies from inside the vessel, offering a sutureless, fully absorbable solution for structural heart and...
Vivasure's PerQseal® Elite...
01/21/2026
Cath Lab Digest
Early CAD Detection
Mammograms and Hidden Heart Disease: Annual Scans Can Detect This Silent Killer and Help Save Lives, but Awareness Is Key
01/21/2026
In the “Mammography and Breast Arterial Calcification Trial at Mount Sinai,” doctors are sending letters to patients with high breast artery calcification levels, urging them to see a cardiologist or other doctor for further evaluation to...
In the “Mammography and Breast Arterial Calcification Trial at Mount Sinai,” doctors are sending letters to patients with high breast artery calcification levels, urging them to see a cardiologist or other doctor for further evaluation to...
In the “Mammography and Breast...
01/21/2026
Cath Lab Digest
Radiation Protection Systems
Cathpax Demonstrates Ability to Offer Interventional Physicians Unmatched Level of Radiation Protection Thanks to First-of-Its-Kind NOVARAD Clinical Study
01/21/2026
Final results of NOVARAD clinical study show that use of Nova-X® full-body, team-wide radiation protection system reduces dose received by main operator in interventional neuroradiology by a factor of eleven.
Final results of NOVARAD clinical study show that use of Nova-X® full-body, team-wide radiation protection system reduces dose received by main operator in interventional neuroradiology by a factor of eleven.
Final results of NOVARAD...
01/21/2026
Cath Lab Digest
Technology & Health Literacy
ECRI: Misuse of AI Chatbots Tops Annual List of Health Tech Hazards
01/21/2026
ECRI experts say that chatbots have suggested incorrect diagnoses, recommended unnecessary testing, promoted subpar medical supplies, and even invented body parts in response to medical questions while sounding like a trusted expert.
ECRI experts say that chatbots have suggested incorrect diagnoses, recommended unnecessary testing, promoted subpar medical supplies, and even invented body parts in response to medical questions while sounding like a trusted expert.
ECRI experts say that chatbots...
01/21/2026
Cath Lab Digest
CAD Risk Factors
North Carolina State University Study Finds Police-Related Stress Associated With Physical Markers of Cardiovascular Health Risk for Black Women
01/19/2026
The paper, “Police-Related Stress and Carotid Intima-Media Thickness Among African American Women,” is published in the journal Biopsychosocial Science and Medicine.
The paper, “Police-Related Stress and Carotid Intima-Media Thickness Among African American Women,” is published in the journal Biopsychosocial Science and Medicine.
The paper, “Police-Related...
01/19/2026
Cath Lab Digest

Bangalore top 10
Author Interview
Editor’s 2025 Top 10: Outcomes With Distal Transradial Access in Patients With Advanced Chronic Kidney Disease
02/02/2026
Sripal Bangalore, MD, MHA; Deepak L. Bhatt, MD, MPH, FACC, FAHA, FESC, MSCAI
Dr Deepak L. Bhatt, editor-in-chief of the Journal of Invasive Cardiology, catches up with Dr Sripal Bangalore about his Editor’s 2025 Top 10 article, “Outcomes With Distal Transradial Access in Patients With Advanced Chronic Kidney Disease.”
Dr Deepak L. Bhatt, editor-in-chief of the Journal of Invasive Cardiology, catches up with Dr Sripal Bangalore about his Editor’s 2025 Top 10 article, “Outcomes With Distal Transradial Access in Patients With Advanced Chronic Kidney Disease.”
Dr Deepak L. Bhatt,...
02/02/2026
Journal of Invasive Cardiology
Editor's 2025 Top 10
Editor's Message
Editor’s 2025 Top 10
02/02/2026
Deepak L. Bhatt, MD, MPH, FACC, FAHA, FESC, MSCAI
Dr Deepak L. Bhatt, Editor-in-Chief of JIC, presents the Top 10 Articles from 2025.
Dr Deepak L. Bhatt, Editor-in-Chief of JIC, presents the Top 10 Articles from 2025.
Dr Deepak L. Bhatt,...
02/02/2026
Journal of Invasive Cardiology
Original Contribution
Early Outcomes of the Myval Octacor Transcatheter Heart Valve in Transcatheter Aortic Valve Implantation: A Single-Center Study From Serbia
01/30/2026
Valentina Balint, MD; Mihajlo Farkic, MD; Jovan Petrovic, MD; Matija Furtula, MD; Milos D. Babic, MD; Dragan Topic, MD; Ida Subotic, MD; Vladimir Zobenica, MD; Alfonso Ielasi, MD; Luca Testa, MD, PhD; Milovan Bojic, MD, PhD; Aleksandra Nikolic, MD, PhD
This study evaluated the early safety and performance of the new Myval Octacor Transcatheter Heart Valve (Meril Life Sciences).
This study evaluated the early safety and performance of the new Myval Octacor Transcatheter Heart Valve (Meril Life Sciences).
This study evaluated the early...
01/30/2026
Journal of Invasive Cardiology
Sovari Figure 1
Clinical Videos
Right Internal Jugular Pulsed Field Ablation for Atrial Fibrillation in a Patient With an Inferior Vena Cava Filter
01/29/2026
Jeong Hwan J. Kim, MD; Leili Pourafkari, MD; Jonathan Lalezari, MD; Ali Sovari, MD
Video Supplement to "Right Internal Jugular Pulsed Field Ablation for Atrial Fibrillation in a Patient With an Inferior Vena Cava Filter" (Clinical Image).
Video Supplement to "Right Internal Jugular Pulsed Field Ablation for Atrial Fibrillation in a Patient With an Inferior Vena Cava Filter" (Clinical Image).
Video Supplement to "Right...
01/29/2026
Journal of Invasive Cardiology
Clinical Images
Right Internal Jugular Pulsed Field Ablation for Atrial Fibrillation in a Patient With an Inferior Vena Cava Filter
01/29/2026
Jeong Hwan J. Kim, MD; Leili Pourafkari, MD; Jonathan Lalezari, MD; Ali Sovari, MD
A 77-year-old man with peripheral arterial disease, sick sinus syndrome, hypertension, and paroxysmal atrial fibrillation (AF) presented for rhythm control. He had a normally functioning dual-chamber pacemaker but had frequent symptomatic AF...
A 77-year-old man with peripheral arterial disease, sick sinus syndrome, hypertension, and paroxysmal atrial fibrillation (AF) presented for rhythm control. He had a normally functioning dual-chamber pacemaker but had frequent symptomatic AF...
A 77-year-old man with...
01/29/2026
Journal of Invasive Cardiology
Clinical Images
Septal Coronary Artery Fistula After Implantation of a Left Bundle Branch Area Pacemaker
01/28/2026
Nicolas Bradt, MD; Maxim Verlee, MD, PhD(c); Christophe Borin, MD; Hans Vandekerckhove, MD; Laurens De Vos, MD
A 51-year-old man with a mixed-phenotype cardiomyopathy was referred for coronary angiography because of new-onset episodes of ventricular arrythmias. At his initial presentation in 2014, he was diagnosed with hypertrophic cardiomyopathy,...
A 51-year-old man with a mixed-phenotype cardiomyopathy was referred for coronary angiography because of new-onset episodes of ventricular arrythmias. At his initial presentation in 2014, he was diagnosed with hypertrophic cardiomyopathy,...
A 51-year-old man with a...
01/28/2026
Journal of Invasive Cardiology
Bradt Figure
Clinical Videos
Septal Coronary Artery Fistula After Implantation of a Left Bundle Branch Area Pacemaker
01/28/2026
Nicolas Bradt, MD; Maxim Verlee, MD, PhD(c); Christophe Borin, MD; Hans Vandekerckhove, MD; Laurens De Vos, MD
Video Supplement to "Septal Coronary Artery Fistula After Implantation of a Left Bundle Branch Area Pacemaker" (Clinical Image).
Video Supplement to "Septal Coronary Artery Fistula After Implantation of a Left Bundle Branch Area Pacemaker" (Clinical Image).
Video Supplement to "Septal...
01/28/2026
Journal of Invasive Cardiology
thrombectomy
Penumbra Launches Lightning Flash 3.0 — The Next Evolution in CAVT Technology
01/27/2026
Penumbra recently launched the Lightning Flash® 3.0 Computer Assisted Vacuum Thrombectomy (CAVT™) system, which includes significant upgrades that further advance our leading venous thromboembolism (VTE) platform.
Penumbra recently launched the Lightning Flash® 3.0 Computer Assisted Vacuum Thrombectomy (CAVT™) system, which includes significant upgrades that further advance our leading venous thromboembolism (VTE) platform.
Penumbra recently launched the...
01/27/2026
Cath Lab Digest
Heart Failure Devices
CVRx Announces Initiation of BENEFIT-HF, a Landmark Heart Failure Trial Evaluating Barostim in Significantly Expanded Population
01/27/2026
The BENEFIT-HF trial is expected to be one of the largest therapeutic cardiac device trials ever performed in heart failure, randomizing 2,500 patients in approximately 150 centers in the United States and Germany. The primary endpoint will...
The BENEFIT-HF trial is expected to be one of the largest therapeutic cardiac device trials ever performed in heart failure, randomizing 2,500 patients in approximately 150 centers in the United States and Germany. The primary endpoint will...
The BENEFIT-HF trial is expected...
01/27/2026
Cath Lab Digest
HighLife TMVR
Mitral Valve Intervention
HighLife Receives CE Mark Approval for its Transcatheter Mitral Valve Replacement (TMVR) Solution
01/27/2026
Paris – HighLife SAS, a leading MedTech company focused on transcatheter solutions for structural heart disease, today announced that it has received CE Mark approval for the HighLife Transcatheter Mitral Valve Replacement...
Paris – HighLife SAS, a leading MedTech company focused on transcatheter solutions for structural heart disease, today announced that it has received CE Mark approval for the HighLife Transcatheter Mitral Valve Replacement...
Paris – HighLife SAS, a...
01/27/2026
Cath Lab Digest

February 2006 Volume 18 Issue 2

View Issue Archive
Editorial Correspondence

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use